Explore our featured stock ideas and investment opportunities to make informed decisions in today's market.
View AllLatest Stonepine Capital Management, LLC Stock Portfolio
$231Million
Equity Portfolio Value
Last Reported on: 13 Feb, 2024
About Stonepine Capital Management, LLC and it’s 13F Hedge Fund Stock Holdings
Stonepine Capital Management, LLC is a hedge fund based in Bend, OR. On 08-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $271.5 Millions. In it's latest 13F Holdings report, Stonepine Capital Management, LLC reported an equity portfolio of $231.2 Millions as of 31 Dec, 2023.
The top stock holdings of Stonepine Capital Management, LLC are EOLS, ADMA, AMLX. The fund has invested 24.3% of it's portfolio in EVOLUS INC and 18% of portfolio in ADMA BIOLOGICS INC.
The fund managers got completely rid off MAXCYTE INC (MXCT), GAMIDA CELL LTD (GMDA) and X4 PHARMACEUTICALS INC (XFOR) stocks. They significantly reduced their stock positions in ATYR PHARMA INC (LIFE), GALAPAGOS NV-SPON ADR (GLPG) and SCYNEXIS INC (SCYX). The fund showed a lot of confidence in some stocks as they added substantially to EVOLUS INC (EOLS), ADMA BIOLOGICS INC (ADMA) and ALIMERA SCIENCES INC (ALIM).
The top stock holdings of Stonepine Capital Management, LLC are EOLS, ADMA, AMLX. The fund has invested 24.3% of it's portfolio in EVOLUS INC and 18% of portfolio in ADMA BIOLOGICS INC.
The fund managers got completely rid off MAXCYTE INC (MXCT), GAMIDA CELL LTD (GMDA) and X4 PHARMACEUTICALS INC (XFOR) stocks. They significantly reduced their stock positions in ATYR PHARMA INC (LIFE), GALAPAGOS NV-SPON ADR (GLPG) and SCYNEXIS INC (SCYX). The fund showed a lot of confidence in some stocks as they added substantially to EVOLUS INC (EOLS), ADMA BIOLOGICS INC (ADMA) and ALIMERA SCIENCES INC (ALIM).
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| EVOLUS INC | 2.97 |
| ADMA BIOLOGICS INC | 1.3 |
| ALIMERA SCIENCES INC | 0.4 |
| XERIS BIOPHARMA HOLDINGS INC | 0.37 |
| AYTU BIOPHARMA INC | 0.02 |
Additions to existing portfolio by Stonepine Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| ATYR PHARMA INC | -89.58 |
| GALAPAGOS NV-SPON ADR | -67.37 |
| SCYNEXIS INC | -52.49 |
| ATEA PHARMACEUTICALS INC | -51.19 |
| EXAGEN INC | -44.35 |
| XOMA CORP | -42.74 |
| TELA BIO INC | -35.4 |
| QUIDELORTHO CORP | -31.69 |
Stonepine Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| GAMIDA CELL LTD | -8,204,840 |
| X4 PHARMACEUTICALS INC | -5,748,320 |
| MAXCYTE INC | -11,736,300 |
| GOSSAMER BIO INC | -2,781,060 |
| ASSERTIO HOLDINGS INC | -2,435,060 |
| DELCATH SYSTEMS INC | -2,779,270 |
| VANDA PHARMACEUTICALS INC | -2,064,540 |
Stonepine Capital Management, LLC got rid off the above stocks
Current Stock Holdings of Stonepine Capital Management, LLC
Last Reported on: 13 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS INC | 18.03 | 9,222,620 | 41,686,200 | ADDED | 1.3 | |
| ALIM | ALIMERA SCIENCES INC | 7.47 | 3,999,460 | 17,277,700 | ADDED | 0.4 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | 15.91 | 2,500,000 | 36,800,000 | REDUCED | -0.63 | |
| ASRT | ASSERTIO HOLDINGS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AVIR | ATEA PHARMACEUTICALS INC | 1.11 | 839,514 | 2,560,520 | REDUCED | -51.19 | |
| AYTU | AYTU BIOPHARMA INC | 0.58 | 472,469 | 1,341,810 | ADDED | 0.02 | |
| DCTH | DELCATH SYSTEMS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| EOLS | EVOLUS INC | 24.29 | 5,333,000 | 56,156,500 | ADDED | 2.97 | |
| GLPG | GALAPAGOS NV-SPON ADR | 4.60 | 261,870 | 10,645,000 | REDUCED | -67.37 | |
| GMDA | GAMIDA CELL LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GOSS | GOSSAMER BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IOBT | IO BIOTECH INC | 1.35 | 1,666,040 | 3,132,150 | REDUCED | -15.66 | |
| LIFE | ATYR PHARMA INC | 0.29 | 482,258 | 679,984 | REDUCED | -89.58 | |
| MXCT | MAXCYTE INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| QDEL | QUIDELORTHO CORP | 14.34 | 450,000 | 33,165,000 | REDUCED | -31.69 | |
| RZLT | REZOLUTE INC | 1.19 | 2,768,660 | 2,747,890 | REDUCED | -9.89 | |
| SCYX | SCYNEXIS INC | 1.31 | 1,355,190 | 3,022,060 | REDUCED | -52.49 | |
| TELA | TELA BIO INC | 0.91 | 317,782 | 2,103,720 | REDUCED | -35.4 | |
| VNDA | VANDA PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 6.03 | 5,937,000 | 13,952,000 | ADDED | 0.37 | |
| XFOR | X4 PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| XGN | EXAGEN INC | 0.58 | 669,684 | 1,332,670 | REDUCED | -44.35 | |
| XOMA | XOMA CORP | 2.00 | 250,000 | 4,625,000 | REDUCED | -42.74 |